DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study)

NCT00748891 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: Recentin (Cediranib)

Sponsor

AstraZeneca

Collaborators

[object Object]